S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
NASDAQ:NOVN

Novan Stock Forecast, Price & News

$8.14
-0.32 (-3.78 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.10
$8.94
50-Day Range
$7.48
$10.17
52-Week Range
$4.33
$25.90
Volume1.20 million shs
Average Volume2.11 million shs
Market Capitalization$153.14 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.02
30 days | 90 days | 365 days | Advanced Chart
Receive NOVN News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.


Novan logo

About Novan

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.25 out of 5 stars

Medical Sector

1140th out of 1,351 stocks

Pharmaceutical Preparations Industry

554th out of 664 stocks

Analyst Opinion: 1.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Novan (NASDAQ:NOVN) Frequently Asked Questions

Is Novan a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Novan stock.
View analyst ratings for Novan
or view top-rated stocks.

What stocks does MarketBeat like better than Novan?

Wall Street analysts have given Novan a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novan wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Novan?

Novan saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 478,200 shares, a drop of 26.5% from the August 15th total of 650,500 shares. Based on an average daily volume of 3,770,000 shares, the short-interest ratio is currently 0.1 days.
View Novan's Short Interest
.

When is Novan's next earnings date?

Novan is scheduled to release its next quarterly earnings announcement on Friday, October 29th 2021.
View our earnings forecast for Novan
.

How were Novan's earnings last quarter?

Novan, Inc. (NASDAQ:NOVN) announced its quarterly earnings data on Thursday, August, 12th. The company reported ($0.39) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.53) by $0.14. The business earned $0.75 million during the quarter, compared to analyst estimates of $0.84 million. Novan had a negative trailing twelve-month return on equity of 274.05% and a negative net margin of 759.49%.
View Novan's earnings history
.

How has Novan's stock been impacted by COVID-19 (Coronavirus)?

Novan's stock was trading at $0.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NOVN shares have increased by 1,465.4% and is now trading at $8.14.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for NOVN?

3 brokers have issued 12-month price targets for Novan's stock. Their forecasts range from $2.00 to $3.00. On average, they expect Novan's share price to reach $2.50 in the next year. This suggests that the stock has a possible downside of 69.3%.
View analysts' price targets for Novan
or view top-rated stocks among Wall Street analysts.

Who are Novan's key executives?

Novan's management team includes the following people:
  • Paula Brown Stafford, Chairman, President & Chief Executive Officer
  • John M. Gay, Chief Financial Officer, Secretary & VP
  • Carri Geer, Chief Technology Officer & Senior Vice President
  • Elizabeth Messersmith, Chief Development Officer & Senior Vice President
  • Tomoko Maeda-Chubachi, Vice President-Medical Dermatology

What other stocks do shareholders of Novan own?

When did Novan IPO?

(NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at a price of $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

What is Novan's stock symbol?

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Who are Novan's major shareholders?

Novan's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.16%), BlackRock Inc. (2.20%), Monashee Investment Management LLC (1.99%), Marshall Wace North America L.P. (1.56%), Marshall Wace LLP (1.23%) and Marshall Wace LLP (1.23%).
View institutional ownership trends for Novan
.

Which institutional investors are selling Novan stock?

NOVN stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., Geode Capital Management LLC, Bridgeway Capital Management LLC, Northern Trust Corp, Morgan Stanley, Morgan Stanley, and Squarepoint Ops LLC.
View insider buying and selling activity for Novan
or view top insider-selling stocks.

Which institutional investors are buying Novan stock?

NOVN stock was acquired by a variety of institutional investors in the last quarter, including Monashee Investment Management LLC, Marshall Wace North America L.P., Marshall Wace LLP, Marshall Wace LLP, Walleye Capital LLC, Principal Financial Group Inc., Laurion Capital Management LP, and Virtu Financial LLC.
View insider buying and selling activity for Novan
or or view top insider-buying stocks.

How do I buy shares of Novan?

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novan's stock price today?

One share of NOVN stock can currently be purchased for approximately $8.14.

How much money does Novan make?

Novan has a market capitalization of $153.14 million and generates $4.92 million in revenue each year. The company earns $-29,290,000.00 in net income (profit) each year or ($2.60) on an earnings per share basis.

How many employees does Novan have?

Novan employs 23 workers across the globe.

What is Novan's official website?

The official website for Novan is www.novan.com.

Where are Novan's headquarters?

Novan is headquartered at 4105 HOPSON ROAD, MORRISVILLE NC, 27560.

How can I contact Novan?

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 485-8080 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.